NM_021098.3:c.2759C>T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.2759C>T(p.Thr920Met) variant causes a missense change. The variant allele was found at a frequency of 0.00259 in 1,574,574 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T920R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.2720C>T | p.Thr907Met | missense_variant | Exon 12 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.2720C>T | p.Thr907Met | missense_variant | Exon 12 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.2759C>T | p.Thr920Met | missense_variant | Exon 12 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*672C>T | non_coding_transcript_exon_variant | Exon 12 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2206C>T | non_coding_transcript_exon_variant | Exon 11 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2759C>T | non_coding_transcript_exon_variant | Exon 12 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*672C>T | 3_prime_UTR_variant | Exon 12 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2206C>T | 3_prime_UTR_variant | Exon 11 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 244AN: 152222Hom.: 2 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00225 AC: 429AN: 190264 AF XY: 0.00222 show subpopulations
GnomAD4 exome AF: 0.00269 AC: 3832AN: 1422234Hom.: 9 Cov.: 31 AF XY: 0.00261 AC XY: 1840AN XY: 703772 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00160 AC: 244AN: 152340Hom.: 2 Cov.: 33 AF XY: 0.00136 AC XY: 101AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
CACNA1H: BS1, BS2 -
- -
- -
See cases Benign:1
ACMG classification criteria: BS1, BP1, BP4 -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at